Oramed Pharmaceuticals Inc. (TLV:ORMP)

Oramed Pharmaceuticals Statistics

Total Valuation

TLV:ORMP has a market cap or net worth of ILS 336.76 million. The enterprise value is -105.23 million.

Market Cap	336.76M
Enterprise Value	-105.23M

Important Dates

The last earnings date was Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	39.80M
Shares Outstanding	n/a
Shares Change (YoY)	+3.29%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	13.27%
Owned by Institutions (%)	10.76%
Float	31.35M

Valuation Ratios

The trailing PE ratio is 2.32.

PE Ratio	2.32
Forward PE	n/a
PS Ratio	50.85
PB Ratio	0.50
P/TBV Ratio	0.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.72
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	3.00

Financial Position

The company has a current ratio of 22.24, with a Debt / Equity ratio of 0.00.

Current Ratio	22.24
Quick Ratio	22.08
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 24.48% and return on invested capital (ROIC) is -4.53%.

Return on Equity (ROE)	24.48%
Return on Assets (ROA)	-4.22%
Return on Invested Capital (ROIC)	-4.53%
Return on Capital Employed (ROCE)	-6.07%
Revenue Per Employee	1.66M
Profits Per Employee	36.30M
Employee Count	4
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, TLV:ORMP has paid 39.52 million in taxes.

Income Tax	39.52M
Effective Tax Rate	21.41%

Stock Price Statistics

The stock price has increased by +0.06% in the last 52 weeks. The beta is 1.19, so TLV:ORMP's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	+0.06%
50-Day Moving Average	764.31
200-Day Moving Average	777.04
Relative Strength Index (RSI)	61.52
Average Volume (20 Days)	18,589

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.61

Income Statement

In the last 12 months, TLV:ORMP had revenue of ILS 6.62 million and earned 145.20 million in profits. Earnings per share was 3.40.

Revenue	6.62M
Gross Profit	43,044
Operating Income	-43.08M
Pretax Income	184.57M
Net Income	145.20M
EBITDA	-42.68M
EBIT	-43.08M
Earnings Per Share (EPS)	3.40

Balance Sheet

The company has 445.96 million in cash and 2.85 million in debt, giving a net cash position of 443.11 million.

Cash & Cash Equivalents	445.96M
Total Debt	2.85M
Net Cash	443.11M
Net Cash Per Share	n/a
Equity (Book Value)	669.93M
Book Value Per Share	16.48
Working Capital	430.44M

Cash Flow

In the last 12 months, operating cash flow was -35.06 million and capital expenditures -59,600, giving a free cash flow of -35.12 million.

Operating Cash Flow	-35.06M
Capital Expenditures	-59,600
Free Cash Flow	-35.12M
FCF Per Share	n/a

Margins

Gross margin is 0.65%, with operating and profit margins of -650.55% and 2,192.60%.

Gross Margin	0.65%
Operating Margin	-650.55%
Pretax Margin	2,787.20%
Profit Margin	2,192.60%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TLV:ORMP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.29%
Shareholder Yield	-3.29%
Earnings Yield	43.12%
FCF Yield	-10.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TLV:ORMP has an Altman Z-Score of 2.8 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.8
Piotroski F-Score	1